Application of PD-L1 blockade in refractory histiocytic sarcoma: A case report

Histiocytic sarcoma (HS) is a rare hematological malignancy, which exhibits morphological and immunophenotypic features of histiocytes. A standard therapy for HS has not yet been established due to its rareness; therefore, disease control is not always possible. A multimodal treatment strategy has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Imataki, Osamu, Uemura, Makiko, Fujita, Haruyuki, Kadowaki, Norimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353867/
https://www.ncbi.nlm.nih.gov/pubmed/35949894
http://dx.doi.org/10.3892/mco.2022.2569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353867/
https://www.ncbi.nlm.nih.gov/pubmed/35949894
http://dx.doi.org/10.3892/mco.2022.2569

Ejemplares similares